Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psychopathological symptoms in parents and siblings of people on the autism spectrum: A systematic review and meta-analysis.
Bispo-Torres AC, Lucena R, Tavares-Rodrigues IC, Barouh JL, Lins-Silva DH, Dorea-Bandeira I, Souza LS, Faria-Guimarães D, Tolentino A, Miranda-Scippa Â, Hermens DF, Sampaio AS, Quarantini LC, Glozier N, Hickie IB, Bandeira ID. Bispo-Torres AC, et al. Among authors: tolentino a. Psychiatry Res. 2023 May;323:115145. doi: 10.1016/j.psychres.2023.115145. Epub 2023 Mar 4. Psychiatry Res. 2023. PMID: 36921507
Efficacy and safety of transcranial direct current stimulation over the left dorsolateral prefrontal cortex in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, triple-blinded, sham-controlled, crossover trial.
Guimarães RSQ, Bandeira ID, Barretto BL, Wanke T, Alves COC, Barretto TL, de Carvalho CF, Dorea-Bandeira I, Tolentino A, Lins-Silva DH, Lucena PH, Lucena R. Guimarães RSQ, et al. Among authors: tolentino a. Front Psychiatry. 2024 Jan 10;14:1217407. doi: 10.3389/fpsyt.2023.1217407. eCollection 2023. Front Psychiatry. 2024. PMID: 38268562 Free PMC article.
Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials.
Krishnan A, Callanan DG, Sendra VG, Lad A, Christian S, Earla R, Khanehzar A, Tolentino AJ, Vailoces VAS, Greene MK, Scott CJ, Kunimoto DY, Hassan TS, Genead MA, Tolentino MJ. Krishnan A, et al. Among authors: tolentino aj. Pharmaceuticals (Basel). 2024 Apr 9;17(4):481. doi: 10.3390/ph17040481. Pharmaceuticals (Basel). 2024. PMID: 38675441 Free PMC article.
STAT6-targeting antisense oligonucleotides against solitary fibrous tumor.
Li Y, Mondaza-Hernandez JL, Moura DS, Revenko AS, Tolentino A, Nguyen JT, Tran N, Meyer CA, Merino-Garcia J, Ramos R, Di Lernia D, Martin-Broto J, Hayenga HN, Bleris L. Li Y, et al. Among authors: tolentino a. Mol Ther Nucleic Acids. 2024 Feb 15;35(2):102154. doi: 10.1016/j.omtn.2024.102154. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38511173 Free PMC article.
90 results